{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:26:36Z","timestamp":1789140396527,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515013289"],"award-info":[{"award-number":["2024A1515013289"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijcha.2024.101512","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:34:01Z","timestamp":1726511641000},"page":"101512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis"],"prefix":"10.1016","volume":"55","author":[{"given":"Xiuying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcha.2024.101512_b0005","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.hrthm.2024.03.017","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"21","author":"Tzeis","year":"2024","journal-title":"Heart Rhythm."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101512_b0010","first-page":"519","article-title":"Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review","volume":"105","author":"Ferreira","year":"2015","journal-title":"Arq Bras Cardiol"},{"issue":"16","key":"10.1016\/j.ijcha.2024.101512_b0015","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101512_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15420\/aer.2018.18.2","article-title":"Risk Factor Management in Atrial Fibrillation","volume":"7","author":"Brandes","year":"2018","journal-title":"Arrhythm Electrophysiol Rev."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101512_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tcm.2022.09.006","article-title":"The relationship between atrial fibrillation and coronary artery disease: Understanding common denominators","volume":"34","author":"Mekhael","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101512_b0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12872-023-03613-0","article-title":"Effect of inflammation on association between cancer and coronary artery disease","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101512_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41569-020-00459-3","article-title":"Stroke prevention strategies in high-risk patients with atrial fibrillation","volume":"18","author":"Kotalczyk","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ijcha.2024.101512_b0040","unstructured":"Van Gelder IC et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Aug 30:ehae176. Epub ahead of print."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101512_b0045","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/STROKEAHA.120.031007","article-title":"Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients","volume":"52","author":"Zhu","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.ijcha.2024.101512_b0050","article-title":"Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101512_b0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/bloodadvances.2017010694","article-title":"Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation","volume":"2","author":"Shah","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijcha.2024.101512_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.breast.2019.05.017","article-title":"Current status of anticoagulation in patients with breast cancer and atrial fibrillation","volume":"46","author":"Pardo Sanz","year":"2019","journal-title":"Breast"},{"issue":"13","key":"10.1016\/j.ijcha.2024.101512_b0065","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1002\/cam4.4012","article-title":"Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants","volume":"10","author":"Ording","year":"2021","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.ijcha.2024.101512_b0070","doi-asserted-by":"crossref","first-page":"e008951","DOI":"10.1161\/CIRCOUTCOMES.122.008951","article-title":"Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation","volume":"15","author":"Mehta","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101512_b0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaccao.2021.06.004","article-title":"Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer","volume":"3","author":"Deitelzweig","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101512_b0080","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1161\/STROKEAHA.120.033470","article-title":"Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Cohort Study","volume":"52","author":"Chan","year":"2021","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101512_b0085","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1055\/s-0041-1728670","article-title":"Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks","volume":"5","author":"Atterman","year":"2021","journal-title":"TH Open"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101512_b0090","doi-asserted-by":"crossref","first-page":"e000290","DOI":"10.1136\/openhrt-2015-000290","article-title":"Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study","volume":"2","author":"Fauchier","year":"2015","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101512_b0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjh.18060","article-title":"Oral anti-coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study","volume":"197","author":"Ording","year":"2022","journal-title":"Br J Haematol."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101512_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101346","article-title":"Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Nonvalvular Atrial Fibrillation and Cancer: A Systematic Review and Network Meta-analysis","volume":"47","author":"Barbarawi","year":"2022","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"10.1016\/j.ijcha.2024.101512_b0105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00228-021-03132-x","article-title":"Safety and efficacy of new oral anticoagulants compared to those of warfarin in AF patients with cancer: a meta-analysis of randomized clinical trials and observational studies","volume":"77","author":"Chen","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"1s","key":"10.1016\/j.ijcha.2024.101512_b0110","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.chest.2020.03.013","article-title":"Randomized Controlled Trials","volume":"158","author":"Zabor","year":"2020","journal-title":"Chest"},{"issue":"1s","key":"10.1016\/j.ijcha.2024.101512_b0115","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.chest.2020.03.014","article-title":"Cohort Studies: Design, Analysis, and Reporting","volume":"158","author":"Wang","year":"2020","journal-title":"Chest"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:59:06Z","timestamp":1751259546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":23,"alternative-id":["S2352906724001787"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101512","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101512"}}